Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy
CardioMET
1 other identifier
observational
3,000
1 country
1
Brief Summary
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedFirst Submitted
Initial submission to the registry
January 21, 2026
CompletedFirst Posted
Study publicly available on registry
January 29, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2027
ExpectedMarch 30, 2026
March 1, 2026
1.1 years
January 21, 2026
March 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Diabetes treatment adherence according to the most recent European Guidelines
Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions.
12-24-36-48 months
Interventions
Data collection on diabetes therapy and follow-up
Eligibility Criteria
Consecutive diabetic patients attending the outpatient clinics, in primary and secondary prevention of cardiovascular disease.
You may qualify if:
- Age ≥ 18 years;
- Diagnosis of type 2 diabetes mellitus (T2DM);
- Stable clinical conditions
- Outpatient settings
- Ability to understand the study procedures and provide written informed consent.
You may not qualify if:
- Patients with type 1 diabetes mellitus;
- Active participation in interventional studies;
- Any condition that may put the patient at risk by participating in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federico II University of Naples, Department of Advanced Biomedical Sciences
Naples, Napoli, 80131, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 4 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 21, 2026
First Posted
January 29, 2026
Study Start
October 1, 2022
Primary Completion
October 31, 2023
Study Completion (Estimated)
October 31, 2027
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share